Exicure Quote - XCUR

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

17.00

Bid

16.71

Offer

17.10

Volume

19,941

16.6453 Day's Range 17.50

1.44 52 Week Range 36.00

Market Cap

36.929M

Previous Close

17.58

Open

16.67

Last Trade

16.8627

Last Trade Time

02:05:08

Financial Volume

US$ 338,086

VWAP

16.9543

Average Volume (3m)

793,942

Shares Outstanding

2,172,323

Dividend Yield

PE Ratio

-2.26

Earnings Per Share (EPS)

-7.79

Revenue

Net Profit

-16.91M

Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA ... Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.exicuretx.com

Headquarters

Wilmington, Delaware, USA

Founded

Exicure Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XCUR. The last closing price for Exicure was US$17.58. Over the last year, Exicure shares have traded in a share price range of US$ 1.44 to US$ 36.00.

Exicure currently has 2,172,323 shares in issue. The market capitalisation of Exicure is US$38.19 million. Exicure has a price to earnings ratio (PE ratio) of -2.26.

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. (“GPCR Therapeutics”) on December 24, 2024...

Form 8-K - Current report

Form 8-K/A - Current report: [Amend]

Form 3 - Initial statement of beneficial ownership of securities

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Please replace the release dated December 20, 2024 with the following corrected version due to multiple revisions. The updated release reads: EXICURE, INC. ANNOUNCES SHAREHOLDERS APPROVE THE $8.7...

Form 8-K - Current report

Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Exicure, Inc. (Nasdaq: XCUR, “the Company”, “Exicure”), today announced that in connection with the change of control transaction approved by the stockholders at the Special Meeting of the...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.91	-10.1004759387	18.91	22.99	16.3999	90269	17.97860112	CS
4	-13.1	-43.5215946844	30.1	32	13.1001	189316	19.46989875	CS
12	14.33	536.70411985	2.67	36	2.15	793942	12.12511744	CS
26	15.315	908.902077151	1.685	36	1.44	1754989	4.78135803	CS
52	14.063	478.821927137	2.937	36	1.44	1076751	4.46576921	CS
156	16.035	1661.65803109	0.965	36	0.423	2537586	1.61695065	CS
260	3.05	21.8637992832	13.95	36	0.423	1856190	2.62695605	CS

XCUR - Frequently Asked Questions (FAQ)

What is the current Exicure share price?

The current share price of Exicure is US$ 17.00

How many Exicure shares are in issue?

Exicure has 2,172,323 shares in issue

What is the market cap of Exicure?

The market capitalisation of Exicure is USD 38.19M

What is the 1 year trading range for Exicure share price?

Exicure has traded in the range of US$ 1.44 to US$ 36.00 during the past year

What is the PE ratio of Exicure?

The price to earnings ratio of Exicure is -2.26

What is the reporting currency for Exicure?

Exicure reports financial results in USD

What is the latest annual profit for Exicure?

The latest annual profit of Exicure is USD -16.91M

What is the registered address of Exicure?

The registered address for Exicure is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Exicure website address?

The website address for Exicure is www.exicuretx.com

Which industry sector does Exicure operate in?

Exicure operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NXUNXU Inc	US$ 0.8521 (250.08%)	177.11M
WATTEnergous Corporation	US$ 1.35 (228.31%)	82.23M
INTZIntrusion Inc	US$ 6.15 (184.72%)	74.28M
VINCVincerx Inc	US$ 0.4351 (124.28%)	155.1M
AHGAkso Health Group	US$ 1.96 (75.00%)	1.06M
ABPAbpro Holdings Inc	US$ 2.705 (-39.76%)	353.75k
TRAWTraws Pharma Inc	US$ 8.24 (-38.60%)	727.34k
LGHLWLion Group Holding Ltd	US$ 0.0046 (-34.29%)	41.65k
LITMSnow Lake Resources Ltd	US$ 1.185 (-25.94%)	31.13M
TOIIWOncology Institute Inc	US$ 0.0081 (-25.69%)	51.3k
NXUNXU Inc	US$ 0.8521 (250.08%)	177.11M
VINCVincerx Inc	US$ 0.4351 (124.28%)	155.1M
XTIAXTI Aerospace Inc	US$ 0.0402 (1.77%)	87.99M
WATTEnergous Corporation	US$ 1.35 (228.31%)	82.23M
INTZIntrusion Inc	US$ 6.15 (184.72%)	74.28M

adamski 1 month ago

Looks like the deal with HiTron is a done deal...what's next...

👍️0

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Exicure Inc (XCUR) Share Price

Exicure Inc (XCUR)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Exicure Inc

Ask ADVFN Intelligence (AI)

XCUR Latest News

XCUR - Frequently Asked Questions (FAQ)

Movers

XCUR Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free